Please assess the completion status of the following clinical trial:

Trial Title: Study in Leucocytes From Patients With Type 1 and Type 2 Diabetes Genetic Markers of Inflammation and Oxidative Stress (TÉLOMÈRES/ CANDIDATE GENES) According to the Type A or Type B Behavior Profile

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients who have provided written informed consent~* Patients with type 1 or type 2 diabetes~* Patient admitted for a consultation, as out or in-patients to the Endocrinology-Diabetology-Metabolic diseases department of Dijon CHU~* Patient \> 18 years~* Patient with either a characteristic Type A behaviour profile (Bortner \> 210), or a characteristic Type B behaviour profile (Bortner\<154)~Exclusion Criteria:~* Persons not covered by national health insurance~* Adults under guardianship or wards of court or not intellectually independent~* Patients without diabetes~* Patients with a mixed A/B behaviour profile (154\< Bortner score \<210)~* Pregnant or breast-feeding women

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Type A behaviour profile (Type: OTHER): None
- Type B behaviour profile (Type: OTHER): None

Based on this trial design, predict the completion outcome and termination type (if applicable).